BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/18/2021 1:32:05 PM | Browse: 331 | Download: 574
 |
Received |
|
2021-03-01 08:53 |
|
Peer-Review Started |
|
2021-03-01 09:04 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-05 09:25 |
|
Revised |
|
2021-06-18 06:25 |
|
Second Decision |
|
2021-08-19 03:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-08-19 07:13 |
|
Articles in Press |
|
2021-08-19 07:13 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-09-17 06:51 |
|
Typeset the Manuscript |
|
2021-09-18 01:26 |
|
Publish the Manuscript Online |
|
2021-09-18 13:32 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Calibration of carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tao Jiang, Jing Wang, Shao-Cheng Lyu, Lin Zhou, Han Li, Qiang He and Ren Lang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Beijing Municipal Science & Technology Commission |
Z181100001718164 |
| Capital's Funds for Health Improvement and Research |
CFH 2020-1-2036 |
|
| Corresponding Author |
Ren Lang, MD, PhD, Academic Fellow, Chief Doctor, Professor, Department of Hepatobiliary Surgery, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gongtinan Road, Chaoyang District, Beijing 100020, China. dr_langren@126.com |
| Key Words |
Distal cholangiocarcinoma; Pancreaticoduodenectomy; Carbohydrate antigen 19-9; γ-glutamyltransferase; Relapse; Prognosis |
| Core Tip |
Distal cholangiocarcinoma (DCC) presents as one of the relatively rare malignant tumors in the digestive system and has a poor long-term prognosis, curative resection is currently the best treatment for patients with DCC because of lacking effective adjuvant therapies, therefore, it is particular significant to accurately predict the prognosis for formulating a reasonable treatment plan and avoiding unnecessary surgical trauma. Carbohydrate antigen 19-9 to serum γ-glutamyltransferase (CA19-9/GGT) was adapted by us as an indicator to minimized the interference effect obstructive jaundice has on the content of CA19-9 level, so as to determine the strong associations between CA19-9/GGT and postoperative neoplasm recurrence and long-term outcome of DCC. |
| Publish Date |
2021-09-18 13:32 |
| Citation |
Jiang T, Lyu SC, Zhou L, Wang J, Li H, He Q, Lang R. Calibration of carbohydrate antigen 19-9 as a novel prognostic biomarker in patients with distal cholangiocarcinoma. World J Gastrointest Surg 2021; 13(9): 1025-1038 |
| URL |
https://www.wjgnet.com/1948-9366/full/v13/i9/1025.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v13.i9.1025 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
